A Radiofrequency Modified Maze and Valve Procedure through a Port-Access Approach
Background: The aim of the study was to assess the feasibility and effectiveness of the irrigated radiofrequency modified maze procedure through a port-access approach during mitral valve surgery.
Methods: Forty-three patients with atrial fibrillation (AF) and mitral valve disease underwent a combined procedure through a port-access approach. The indication was a history of continuous AF for more than 6 months in patients eligible for minimally invasive mitral valve surgery.
Results: The incidence of early mortality was 1 patient (2.3%), and that of freedom from AF was 100% at the end of the operation (70% of patients with normal sinus rhythm, 30% with a pacemaker). One patient (2.3%) required permanent pacemaker implantation after surgery. One patient (2.3%) required reoperation for bleeding. There were no reoperations for failed valve repairs. The incidences of freedom from AF were 87% and 92% at 6 and 12 months, respectively. At 12 months, functional capacity had improved significantly (P < .05). There were no procedure-related complications. No thromboembolic events were detected during follow-up.
Conclusion: The port-access approach provided a good access for both valve surgery and the radiofrequency maze procedure. The combination of direct and videoscopic vision allowed an adequate view and led to a safe and efficient combined procedure. Short- and intermediate-term follow-up results were favorable.
Usui A, Inden Y, Mizutani S, Takagi Y, Akita T, Ueda Y. 2002. Repetitive atrial flutter as a complication of the left-sided simple maze procedure. Ann Thorac Surg 73:1457-9.nBenjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. 1998. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946-52.nBenussi S, Pappone C, Nascimbene S, et al. 2000. A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach. Eur J Cardiothorac Surg 17:524-9.nCox JL, Schuessler RB, D'Agostino HJ Jr, et al. 1991. The surgical treatment of atrial fibrillation, III: development of a definitive surgical procedure. J Thorac Cardiovasc Surg 101:569-83.nFeinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. 1995. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469-73.nGillinov AM, Pettersson G, Rice TW. 2001. Esophageal injury during radiofrequency ablation for atrial fibrillation. J Thorac Cardiovasc Surg 122:1239-40.nGüden M, Akpinar B, Sanisoglu I, Sagbas E, Bayindir O. 2002. Intraoperative saline-irrigated radiofrequency modified maze procedure for atrial fibrillation. Ann Thorac Surg 74:S1301-6.nKhargi K, Deneke T, Haardt H, et al. 2001. Saline-irrigated, cooled-tip radiofrequency ablation is an effective technique to perform the maze procedure. Ann Thorac Surg 72:S1090-5.nKosaka Y. 1999. Maze procedure for atrial fibrillation. In: Franco KL, Verrier ED, editors. Advanced therapy in cardiac surgery. St. Louis, Mo: B. C. Decker. p 250-7.nKress DC, Krum D, Chekanov V, et al. 2002. Validation of a left atrial lesion pattern for intraoperative ablation of atrial fibrillation. Ann Thorac Surg 73:1160-8.nLee JW, Choo SJ, Kim KI, et al. 2001. Atrial fibrillation surgery simplified with cryoablation to improve left atrial function. Ann Thorac Surg 72:1479-83.nMelo JQ, Adragao P, Neves J, et al. 2001. Surgery of atrial fibrillation with intraoperative radiofrequency [in Portuguese]. Rev Port Cardiol 20(suppl 5)V-189-91.nMohr FW, Fabricius AM, Falk V, et al. 2002. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: short-term and midterm results. J Thorac Cardiovasc Surg 123:919-27.nPatwardhan AM, Dave HH, Tamhane AA, et al. 1997. Intraoperative radiofrequency microbipolar coagulation to replace incisions of maze III procedure for correcting atrial fibrillation in patients with rheumatic valvular disease. Eur J Cardiothorac Surg 12:627-33.nPatwardhan AM, Lad VS, Pai V. 2002. Esophageal injury during radiofrequency ablation for atrial fibrillation: inherent safety of radiofrequency bipolar coagulation. J Thorac Cardiovasc Surg 124:642-3.nSharony R, Grossi EA, Ribakove GH, Ursomanno P, Colvin SB, Galloway AC. 2002. Minimally invasive valve surgery: evolution of technique and clinical results. Adv Cardiol 39:164-72.nSie HT, Beukema WP, Misier AR, et al. 2001. Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery. J Thorac Cardiovasc Surg 122:249-56.nSie HT, Beukema WP, Ramdat Misier AR, Elvan A, Ennema JJ, Wellens HJ. 2001. The radiofrequency modified maze procedure: a less invasive surgical approach to atrial fibrillation during open-heart surgery. Eur J Cardiothorac Surg 19:443-7.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).